Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Perspectives in Clinical Research|June 5, 2018
Investigator preparedness for monitoring and auditsRenju Ravi, Debdipta Bose, Nithya J Gogtay, et al.
Perspectives in Clinical Research|July 17, 2020
Recruitment and retention of the participants in clinical trials: Challenges and solutionsNayan Chaudhari, Renju Ravi, Nithya J Gogtay, et al.
Reviews on Recent Clinical Trials|July 14, 2021
An Audit of Interim Analyses of Randomized Controlled Trials (RCTs) Published in Three High Impact Factor Medical Journals Over a Seven- year Period (2012-2018)Debdipta Bose, Renju Ravi, Nithya Gogtay, et al.
Indian Journal of Medical Ethics|November 3, 2021
An analysis of invitations for article submission received via emailsSandeep B Bavdekar, Shruti Saha, Urmila M Thatte, et al.
Indian Journal of Pharmacology|April 2, 2013
Insulin sensitizing effect of 3 Indian medicinal plants: an in vitro studySamidha A Kalekar, Renuka P Munshi, Supriya S Bhalerao, et al.
Perspectives in Clinical Research|January 25, 2021
An audit of reporting of conflict of interest policies among three stakeholders in Indian biomedical journalsDebdipta Bose, Shagun Nasta, Renju Ravi, et al.
Perspectives in Clinical Research|April 23, 2019
Current status of standardized, quality and ethical oversight of clinical research in the country: An audit of the Central Drugs Standard Control Organization (registration of ethics committees) and national accreditation board for hospital and healthcare providers (accreditation) databasesTushar Bhimrao Nishandar, Amit Ravindra Birajdar, Nithya J Gogtay, et al.
Current Reviews in Clinical and Experimental Pharmacology|August 30, 2021
A Systematic Review and Meta-Analysis of the Safety of Hydroxychloroquine in a Randomized Controlled Trial and Observational StudiesMahanjit Konwar, Miteshkumar Maurya, Urmila M Thatte, et al.
Indian Journal of Medical Ethics|June 29, 2022
An audit of US FDA warning letters issued to sponsors, institutional review boards and investigators over a six-year periodUnnati Saxena, Debdipta Bose, Shruti Saha, et al.
Perspectives in Clinical Research|March 11, 2020
A comparative study to evaluate quality of data documentation between investigator-initiated and pharmaceutical industry-sponsored studiesBrinal H Figer, Keyur P Sapra, Nithya J Gogtay, et al.
Pageof 6